Brand family
Viokace
Pancrelipase amylase, Pancrelipase lipase and Pancrelipase protease · Aimmune Therapeutics
United States
- Presentations
- 2
- Markets
- 1
Viokace is a brand of Pancrelipase amylase, Pancrelipase lipase and Pancrelipase protease marketed by Aimmune Therapeutics, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Pancrelipase amylase, Pancrelipase lipase and Pancrelipase protease
- Brand owner
- Aimmune Therapeutics
- Registered in
- United States
- Strengths and forms
- 39150 units/10440 units/39150 units tablet, 78300 units/20880 units/78300 units tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Viokace 39150 units/10440 units/39150 units tabletOral | Aimmune Therapeutics | US FDA | Available on request |
| Viokace 78300 units/20880 units/78300 units tabletOral | Aimmune Therapeutics | US FDA | Available on request |
Equivalent brands
Other brands of Pancrelipase amylase, Pancrelipase lipase and Pancrelipase protease.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Viokace
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.